Key result
Arrhythmogenic cardiomyopathy risk stratification requires integrating clinical history, electrical parameters, and advanced imaging.
Why the study?
Arrhythmic risk stratification is essential for managing patients with arrhythmogenic cardiomyopathy but remains a clinical challenge.
A multiparametric approach combining clinical, electrical, and imaging parameters is essential for accurate arrhythmic risk stratification in patients with arrhythmogenic cardiomyopathy.
Answers are grounded in this paper and cite their sources.
Supports multiparametric risk stratification in arrhythmogenic cardiomyopathy; leaves open prospective validation of integrated models.
Arrhythmogenic cardiomyopathy is a heart disease in which the heart muscle is replaced by scar tissue. This is the main substrate for the development of malignant ventricular arrhythmias. Sudden cardiac death is the most common manifestation and can often be the first sign of the disease, especially in young people. Correct stratification of arrhythmic risk is essential for the management of these patients but remains a challenge for the clinical cardiologist. In this context, the aim of our work was to review the literature and to analyse the most important studies and new developments with regard to the stratification of the risk of arrhythmia in patients suffering from arrhythmogenic cardiopathy.
No takes yet. Share an insight, caveat, or question.
Varrenti et al. (2025) conducted a review in Arrhythmogenic Cardiomyopathy. Risk stratification predictors was evaluated. Arrhythmic risk stratification in arrhythmogenic cardiomyopathy requires a multiparametric approach integrating clinical history, electrical parameters, and advanced imaging modalities like cardiac magnetic resonance.
Synapse has enriched 10 related papers. Consider them for comparative context: